Adagio Therapeutics, Inc. (ADGI) Financials

NASDAQ Currency in USD Disclaimer

$4.64

north_east NA Past Year
Day's range
$4.4
Day's range
$4.74
$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200M-$250M-$250MEarning202120215%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

ADGI Income statement / Annual

Last year (2021), Adagio Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2021, Adagio Therapeutics, Inc.'s net income was -$226.79 M. See Adagio Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021
Period Ended 12/31/2021
Operating Revenue $0.00
Cost of Revenue $0.00
Gross Profit $0.00
Gross Profit Ratio 0
Research and Development Expenses $182.89 M
General & Administrative Expenses $0.00
Selling & Marketing Expenses $0.00
Selling, General & Administrative Expenses $36.52 M
Other Expenses $7.50 M
Operating Expenses $226.91 M
Cost And Expenses $226.91 M
Interest Income $0.00
Interest Expense $0.00
Depreciation & Amortization $1.43 M
EBITDA -$225.36 M
EBITDA Ratio 0
Operating Income Ratio 0
Total Other Income/Expenses Net $118,000.00
Income Before Tax -$226.79 M
Income Before Tax Ratio 0
Income Tax Expense $118,000.00
Net Income -$226.79 M
Net Income Ratio 0
EPS -2.04
EPS Diluted -2.04
Weighted Average Shares Out $111.25 M
Weighted Average Shares Out Diluted $111.25 M
Link